Estradot 25, 37.5, 50, 75 and 100 micrograms/24 hours, transdermal patches
Last Updated on eMC 01-Jun-2016 View document | Novartis Pharmaceuticals UK Ltd Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 01-Jun-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 14-Mar-2016 and displayed until 01-Jun-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 5 - how to store
- Change to section 6 - date of revision
Updated on 21-Apr-2015 and displayed until 14-Mar-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 13-Jun-2014 and displayed until 21-Apr-2015
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 14-May-2012 and displayed until 13-Jun-2014
Reasons for adding or updating:
- Change due to harmonisation of PIL.
- Change to drug interactions
Updated on 21-Jun-2011 and displayed until 14-May-2012
Reasons for adding or updating:
- Change to date of revision
- Unknown
Updated on 25-Mar-2010 and displayed until 21-Jun-2011
Reasons for adding or updating:
- Introduction of new pack/pack size
Updated on 25-Sep-2009 and displayed until 25-Mar-2010
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 01-May-2009 and displayed until 25-Sep-2009
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 18-Mar-2005 and displayed until 01-May-2009
Reasons for adding or updating:
- New PIL for new product
Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
+44 (0)1276 692 255
+44 (0)1276 698 370
+44 (0)845 741 9442
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue